We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aurobindo Hit With Patent Infringement Suit Over Generic Movantik
Aurobindo Hit With Patent Infringement Suit Over Generic Movantik
AstraZeneca and Nektar Therapeutics hit Aurobindo with a patent infringement suit in a Delaware federal court over Aurobindo’s generic version of their constipation drug Movantik (naloxegol).